Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02409303 · ClinicalTrials.gov registry record · NA
An SRT Model for Early Access to ASD Intervention
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 627
- Enrollment target
NCT02409303: Completed NA study, sponsored by University of Washington.
NCT02409303 is a NA study that has completed, run by University of Washington. The registered enrollment target is 627 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02409303, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 627 participants
- Enrollment target
Study Summary
This project will implement and evaluate an innovative healthcare service delivery model designed to promote earlier access to specialized intervention for toddlers with ASD. The Screen-Refer-Treat (SRT) model provides a coordinated and cost-effective approach to early identification and intervention by involving both medical and EI providers, and represents a practical and sustainable strategy for bridging the gap between ASD concerns and ASD intervention.
Primary Outcome
PCP self-report
Interventions
- BEHAVIORAL Screen-Refer-Treat Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 627 participants |
| Start Date | 2015-07 |
| Est. Completion | 2019-06 |
| Phase | NA |
What the finished NCT02409303 record still lists
NCT02409303 is an interventional study that assigns participants to a tested intervention. The registered 627 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 1 intervention - of which Screen-Refer-Treat Intervention is the first listed.
NCT02409303 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02409303 about?
NCT02409303 is a clinical study titled "An SRT Model for Early Access to ASD Intervention". This project will implement and evaluate an innovative healthcare service delivery model designed to promote earlier access to specialized intervention for toddlers with ASD. The Screen-Refer-Treat (SRT) model provides a coordinated and cost-effective approach to early identification and interventio...
What is the current status of trial NCT02409303?
This trial is currently completed. It is a NA study. The enrollment target is 627 participants. The study started on 2015-07. Estimated completion is 2019-06.
What interventions are being tested in trial NCT02409303?
The interventions under investigation include: Screen-Refer-Treat Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02409303?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02409303's enrollment target sits among peer trials
627 160th of 2000 higher than 1,841 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06040827 · 626 participants
A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension
- NCT05349227 · 625 participants · NA
Comprehensive Outcomes for After Cancer Health
- NCT06103864 · 625 participants · Phase 3
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
- NCT06230510 · 625 participants · NA
Milk-Tot Study: Impact of Whole Versus Low-fat Milk on Child Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia